Nagano, Japan

Hiroshi Tomiyama

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 323(Granted Patents)


Location History:

  • Hanishina-gun, JP (2002 - 2003)
  • Nagano-ken, JP (2003 - 2005)
  • Tokyo, JP (2010 - 2011)
  • Sakaki-machi, JP (2010 - 2011)
  • Chuo-ku, JP (2016)
  • Nagano, JP (2005 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Hiroshi Tomiyama: Pioneering Innovations in Cancer Treatment

Introduction: Hiroshi Tomiyama, a visionary inventor hailing from Nagano, Japan, has made significant contributions to the field of healthcare with his groundbreaking patents and inventions. With a total of 17 patents to his name, Tomiyama's work has been instrumental in developing cutting-edge solutions for cancer treatment.

Latest Patents:

1. Diamino Heterocyclic Carboxamide Compound: Tomiyama's invention of this compound has proven to be a potent inhibitor against the kinase activity of the EML4-ALK fusion protein. This compound shows promising potential as a pharmaceutical composition for the prevention and treatment of various forms of cancer, including lung cancer.

2. Nitrogen-Containing Aromatic Heterocyclic Compound: Another remarkable invention by Tomiyama, this compound serves as a prophylactic and therapeutic agent for bladder cancer. Its inhibitory action on FGFR1, FGFR2, and FGFR3, especially mutant FGFR3, positions it as a valuable asset in the treatment of cancers related to these receptors.

Career Highlights: Throughout his career, Hiroshi Tomiyama has worked with esteemed companies such as Kotobuki Pharmaceutical Co Ltd and Astellas Pharma GmbH. His innovative spirit and dedication to advancing healthcare technologies have garnered him recognition as a key player in the industry.

Collaborations: Tomiyama's collaborative efforts with esteemed colleagues like Atsushi Noda and Yoshinori Kobayashi have further amplified the impact of his inventions. Together, they have pushed the boundaries of cancer research and treatment, paving the way for novel therapeutic interventions.

Conclusion: Hiroshi Tomiyama stands at the forefront of innovation in the realm of cancer treatment, with his pioneering inventions shaping the future of healthcare. His patents not only reflect his scientific acumen but also his unwavering commitment to improving patient outcomes and revolutionizing the field of oncology. Tomiyama's legacy serves as an inspiration to aspiring inventors, urging them to dream big and embark on a journey of discovery and invention that has the power to transform lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…